Recent pharmaceutical cases in regulatory and intellectual property law have resulted in developments on several fronts, including:

  • regulatory matters;
  • patent validity and damages;
  • Patented Medicines (Notice of Compliance) Regulations proceedings; and
  • class actions.

In this paper, we review some of the most notable Canadian decisions from 2015 that will continue to impact the legal landscape for the pharmaceutical industry in Canada over the coming year.

Download the brochure here: 2015 Pharma in Brief (pdf 2.15MB)



Practice area:

Industry:

Recent publications

Illustration of the Canada Government building on a muted grape background

Publication

2024 Canadian Federal Budget: Tax Administration and Tax Disputes Measures

The Canadian Federal Budget 2024 proposes to broaden the scope of certain powers allowing CRA to request information from taxpayers, and sets out new consequences for non-compliant taxpayers.

Canada | April 17, 2024

Tax
Illustration of the Canada Government building on a bright mint background

Publication

2024 Canadian Federal Budget: Employee Ownership Trusts

The Canadian Federal Budget 2024 provides additional details on the $10 million exemption from taxation on capital gains realized on the sale of a business to an Employee Ownership Trust.

Canada | April 17, 2024

Tax
Illustration of the Canada Government building on a dark grape background

Publication

2024 Canadian Federal Budget: Capital Gains

The Canadian Federal Budget 2024 proposes to increase the capital gains inclusion rate.

Canada | April 17, 2024

Tax
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Subscribe now